meRfi®-GM
Cyclophosphamide & Tumor Microenvironment (TME)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
References (Sources)
- A randomised phase II study of sialyl-Tn & DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer
- DNA demethylating agent 5-azacytidine inhibits myeloid-derived suppressor cells induced by tumor growth and cyclophosphamide treatment
- Low Dose Cyclophosphamide Modulates Tumor Microenvironment by TGF-beta Signaling Pathway